ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

Is a Good Night's Sleep at the Top of Your Wishlist?

Ashwagandha Helps Hormones - Aids Arthritis

Why You Should Be Eating More Porcini Mushrooms

A Breathalyzer for Disease?

How Bacopa Can Help Improve Your Cognitive Function

Magnesium Reduces Diabetes and Helps Keep You Young

Lavender Aromatherapy Can Ease Pre-Op Anxiety

Give Your Health a Much-Needed Boost With Geranium

The Role of Resveratrol in Achieving Optimal Health

Could Coconut Oil Help Reduce Antibiotics?

 
Print Page
Email Article

Phase II Clinical Trial Opens for New Oral Rheumatoid Arthritis Treatment

  [ 25 votes ]   [ Discuss This Article ]
www.ProHealth.com • March 15, 2002




The pharmaceutical company Scios Inc., recently announced enrollment has begun in a Phase IIa clinical trial evaluating a new oral treatment for rheumatoid arthritis (RA) called, SCIO-469, a novel p38 kinase inhibitor.

"SCIO-469 could become a valuable new oral treatment for the millions of RA patients affected by this disease worldwide," said Darlene P. Horton, M.D., Scios' Vice President of Medical Affairs.

This multi-center, randomized, placebo-controlled clinical study will enroll 120 patients who have active RA and are receiving methotrexate. The main objective of the study is to evaluate the safety and tolerability of six escalating doses of SCIO-469 in RA patients. Results are expected to be announced in early 2003.

SCIO-469 belongs to a new class of treatments that inhibit p38 kinase, a stimulatory regulator of pro-inflammatory factors including tumor necrosis factor-alpha (TNF-alpha), interleukin-1 (IL-1), and cyclooxygenase-2 (COX-2), all of which are known to contribute to both symptoms and disease progression in patients with RA.

Preclinical data has shown that SCIO-469 leads to the suppression of TNF-alpha levels over a wide range of doses, and two Phase I studies demonstrated that doses in the ranges tested were well tolerated in healthy volunteers.

Existing protein-based products that antagonize TNF-alpha are prescription products administered only through injection or infusion. If approved, SCIO-469 would be the first specific oral product aimed at reducing TNF-alpha.

RA is a progressively worsening autoimmune disease of unknown origin in which the body's natural immune system attacks healthy joint tissue causing inflammation and joint damage. RA is a systemic disease that affects the entire body and is one of the most common forms of arthritis. It is characterized by inflammation of the membrane lining the joint, which causes pain, stiffness, warmth, redness and swelling. The inflamed joint lining, the synovium, can invade and damage bone and cartilage. The involved joint can lose its shape and alignment, resulting in pain and loss of movement. According to the Arthritis Foundation, rheumatoid arthritis affects 2.1 million Americans.





Post a Comment

Featured Products From the ProHealth Store
FibroSleep™ Ultra EPA  - Fish Oil Energy NADH™ 12.5mg


Article Comments



Be the first to comment on this article!

Post a Comment


 
Optimized Curcumin Longvida with Omega-3

Featured Products

Ultra ATP+, Double Strength Ultra ATP+, Double Strength
Get energized with malic acid & magnesium
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Optimized Curcumin Longvida® Optimized Curcumin Longvida®
Supports Cognition, Memory & Overall Health

Natural Remedies

Guarding Against the Dangers of Vitamin D Deficiency Guarding Against the Dangers of Vitamin D Deficiency
Clinically Studied Joint Relief Product for FM & ME/CFS Clinically Studied Joint Relief Product for FM & ME/CFS
Block food Cravings At Their Molecular Root Block food Cravings At Their Molecular Root
How Glutathione Can Save Your Life How Glutathione Can Save Your Life
Three-Step Strategy to Reverse Mitochondrial Aging Three-Step Strategy to Reverse Mitochondrial Aging

CONTACT US
ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
SHOP WITH CONFIDENCE
Credit Card Processing
SUBSCRIBE TO OUR NEWSLETTERS
Get the latest news about Fibromyalgia, M.E/Chronic Fatigue Syndrome, Lyme Disease and Natural Wellness

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2017 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map